glorikian.com
Why do many IVD companies face an uphill battle with payers for reimbursement?
Why do many IVD companies face an uphill battle with payers for reimbursement? The demise of Courtagen Life Sciences earlier this year brought increased attention to a long-standing problem for the in vitro diagnostic (IVD) industry, particularly for genetic tests: getting reimbu